Background Human papillomavirus (HPV) vaccines were first licensed as a three-dose
series. Two doses are now widely recommended in some age groups; there are data …

Gay, bisexual, and other men who have sex with men (MSM) and transgender women,
particularly those who are living with HIV, are disproportionately affected by human …

Objective and Participants: In 2006, the authors examined intention to receive an HPV
vaccine among 340 college students. Methods: A total of 138 men and 202 women …

Human papillomavirus (HPV) is a critical factor in the development of cervical cancer and
can lead to genital warts and other clinical sequelae. Two vaccines against HPV have been …

Gay and bisexual men are at increased risk of anal cancer as a result of human
papillomavirus (HPV) infection. Prophylactic vaccination is a potentially effective strategy for …

Objective The objective of this study was to provide a systematic review of peer-reviewed
literature on the factors associated with HPV vaccine acceptability among adults in African …

Background The human papillomavirus (HPV) is the most common sexually transmitted
infection and is linked to several types of cancer. HPV vaccination uptake in the US is …

The human papillomavirus (HPV) causes several cancers and genital warts among sexually
active adolescent and young adult (AYA) males. Quadrivalent HPV vaccines were approved …

Human papillomavirus (HPV) vaccines are now included in immunisation programmes in 71
countries. Unfortunately, uptake has been impacted in some countries by reduced …

Human papillomavirus (HPV) is the necessary cause of cervical cancer, the fourth most
common cancer and cause of cancer-related death in females worldwide. HPV also causes …